Adcal

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adcal

Quick Facts

Property Description
Active Ingredients Calcium Carbonate & Colecalciferol (Vitamin D3)
Form Oral (commonly Chewable Tablet)
Pharmacological Class Combined Calcium and Vitamin D Supplement
Common Use Maintaining bone health; correcting nutritional deficiencies
Origin Mineral (Calcium Salt) and Synthesized Nutrient (Vitamin D3)

What Type of Supplement is Adcal? (Its Class and Purpose)

Adcal is a branded, prescribed medicinal product that belongs to the pharmacological class of combined Calcium and Vitamin D supplements. It is specifically designed to provide essential nutrients to help maintain bone health and correct nutritional deficiencies of these substances, often dispensed as a prescription-only medicine (Rx).

As a therapeutic agent, Adcal is not a simple food supplement; it is licensed and formulated to deliver specific, high-strength doses. Combined vitamin D and calcium supplements are utilized for preventing and managing deficiencies that impact bone integrity. This product is designed as a medically targeted solution, recognized for its combined-nutrient approach.

The Core Components: Ingredients and Formulation

The core components in Adcal are Calcium Carbonate and Colecalciferol (Vitamin D3), which are combined into an oral dosage form, most commonly a chewable tablet. The Calcium Carbonate provides the fundamental mineral needed for bone strength, while Colecalciferol is the nutrient that facilitates its absorption.

This formulation is frequently presented as a chewable tablet or granule, an oral delivery system designed for convenience and effective breakdown. Such combined calcium and vitamin D products are used to ensure the simultaneous provision of the mineral and the agent needed for its utilization. This specific format is a key feature, making it suitable for patient populations who may have difficulty swallowing conventional pills.

Adcal's Essential Role in Supporting Bone Health

Adcal’s essential role is to support the body’s natural maintenance processes by restoring optimal levels of calcium and Vitamin D, which are necessary for strong, healthy bones and teeth. This action is crucial for maintaining proper bone mineral density and preventing complications associated with long-term nutrient shortfalls.

The dual ingredients provide comprehensive support: the mineral calcium provides the material, and the Vitamin D enables the body to properly absorb and deposit it. This combined support is vital for maintaining the skeletal system's resilience, particularly in scenarios clinically recognized as high-risk for deficiency, such as in older adults or individuals with restricted sun exposure.

What side effects are possible with Adcal ?

Possible Side Effects and Safety Information

The safety profile of Adcal (Calcium Carbonate and Colecalciferol) is formally structured by regulatory authorities based on the expected occurrence and type of adverse reactions.

Adverse reactions are classified into physiological groups, with effects primarily documented in the Gastrointestinal Disorders and Metabolism and Nutrition Disorders System-Organ Classes.


Frequency-Classified Adverse Reactions

Adverse effects are categorized by frequency, based on clinical data and post-marketing surveillance:

Classification Examples of Reactions
Rare (Up to 1 in 1,000 people) Constipation, flatulence, nausea, stomach ache, diarrhea, rash, pruritus, urticaria.
Very Rare (Up to 1 in 10,000 people) Milk-alkali syndrome.
Frequency Not Known Serious hypersensitivity reactions, including angioedema or oropharyngeal swelling.

Serious Adverse Reactions and Safety Constraints

The regulatory profile identifies hypercalcaemia (excessive calcium in the blood) and hypercalciuria (excessive calcium in the urine) as significant adverse reactions associated with long-term treatment at high dosages.

Certain pre-existing conditions are defined as contraindications for use, including severe renal failure, pre-existing hypercalcaemia, and severe hypercalciuria. Specific caution is required for patient populations such as those with mild-to-moderate renal impairment or sarcoidosis.

During extended treatment periods, official safety statements advise monitoring of serum calcium, urinary calcium levels, and kidney function (plasma creatinine). This framework ensures that the medicine's potential for metabolic imbalance is managed within a formal regulatory context.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define overdose for Adcal (Calcium Carbonate and Colecalciferol) based on resulting biochemical disturbances.

Documented Manifestations and Severe Outcomes

Overdose typically presents as hypercalcaemia (abnormally high blood calcium levels) and hypervitaminosis D. Initial signs listed by regulators include severe thirst (polydipsia), increased urination (polyuria), nausea, vomiting, constipation, and fatigue. Specific neurological symptoms such as mental disturbances are also officially noted as presentations.

Authorities classify severe outcomes that may arise from extreme or chronic hypercalcaemia. These include serious risks of cardiac arrhythmias, irreversible renal damage (nephrocalcinosis), and potential progression to coma or death. Long-term hypercalcaemia in pregnancy is documented as having serious potential consequences for the newborn.

Mandated Emergency Action

Immediate medical attention is officially required upon the suspicion of an overdose. Go to the nearest hospital casualty department immediately for assessment, taking the product packaging. The official label notes that no specific antidote is known, and treatment is classified as symptomatic and supportive.

Supportive management involves the immediate discontinuation of calcium and vitamin D treatment. Monitoring protocols include assessment of renal function, serum electrolytes, and, in severe cases, the use of ECG and CVP.

Therapeutic Uses of Adcal

What Adcal Treats: Main Uses and Benefits

Adcal is generally used in therapeutic domains that involve symptoms related to physical discomfort and systemic imbalance arising from deficiencies in calcium and vitamin D. This medication is commonly used to help with conditions presenting with systemic or localized discomfort, such as osteoporosis and related issues, as well as for supportive nutritional supplementation where dietary intake is inadequate.

The medication is indicated for use in easing symptoms in situations where patients experience these deficiencies. It may assist with maintaining functional stability and provides support that contributes to easing the overall symptom load associated with skeletal fragility and muscle discomfort.

“This medication supports general well-being during symptomatic phases, helping patients manage symptoms that interfere with daily comfort.”

In clinical use, this medication is applied to address symptoms of muscle weakness, cramps, and general aches that are often linked to low calcium and vitamin D levels. It helps address symptom clusters that can create noticeable physiological strain, which may help patients cope more steadily with symptom fluctuations.


Quick Fact: Supportive Management for Skeletal and Muscle Symptoms Adcal is commonly used to help manage the symptoms of bone fragility and muscle weakness linked to long-term nutritional shortfalls.

Eligibility and Restrictions for Use

Who Can and Cannot Use Adcal?

The official regulatory profile for Adcal (Calcium Carbonate & Colecalciferol) strictly defines population eligibility based primarily on the risk of calcium imbalance and kidney function, as documented in government labeling.

Eligibility Scope

Classification Population or Condition
Populations Contraindicated Hypercalcaemia (high blood calcium), Hypervitaminosis D (Vitamin D overdosage), Severe renal failure/impairment, Sarcoidosis, Primary hyperparathyroidism, or Hypersensitivity to ingredients.
Use Not Recommended Children under 12 years of age.

Condition-Based Eligibility

Adcal is formally approved for use in Adults and the Elderly, including those requiring supplementation alongside specific osteoporosis treatment.

Use during pregnancy and lactation is permitted, but must always be under the direction of a physician, with strict avoidance of hypercalcaemia.

Patients with mild to moderate renal failure or a history of renal stones are not absolutely prohibited but require careful supervision and periodic monitoring of blood and urinary calcium levels, as stipulated in official regulatory documents.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions involving Adcal (Calcium Carbonate and Cholecalciferol) are categorized by their effect on drug absorption and their combined effects on calcium levels.

Absorption-Based Interactions (Timing Separation Required)

Adcal's calcium component can bind to and reduce the absorption of several oral medicines. To prevent this, strict time separation is required between Adcal and the following substances:

  • Antibiotics: Tetracyclines (e.g., Doxycycline) and Quinolones (e.g., Ciprofloxacin) must be administered hours before or after Adcal.
  • Bone treatments: Bisphosphonates and strontium ranelate require time separation.
  • Other Agents: Levothyroxine (thyroid hormone) and certain mineral supplements (Iron, Zinc) must be separated by several hours.

Metabolic and Pharmacodynamic Interactions

These combinations affect the metabolism of Vitamin D or the excretion of calcium, potentially leading to hypercalcaemia.

  • Cardiovascular Drugs: Use with Cardiac Glycosides (e.g., Digoxin) is hazardous due to the increased toxicity risk posed by elevated calcium levels. Thiazide Diuretics reduce urinary calcium excretion, requiring close monitoring.
  • Antiepileptics: Medications such as Phenytoin and Barbiturates may increase the metabolism of Vitamin D, potentially reducing Adcal's effect.
  • Corticosteroids: Systemic glucocorticoids can reduce calcium absorption, possibly necessitating a higher Adcal dose.

Dietary Interactions

Foods high in Oxalic Acid (e.g., spinach, rhubarb) and Phytic Acid (e.g., whole cereals) can inhibit calcium absorption. Taking Adcal within two hours of consuming these foods should be avoided.

Mechanism of Action

Adcal provides an exogenous source of calcium carbonate and colecalciferol (Vitamin D3). Following oral administration, the calcium component is absorbed in the small intestine primarily via transcellular and paracellular transport pathways to enter systemic circulation as the principal substrate for skeletal and non-skeletal homeostatic processes.

The colecalciferol component undergoes sequential hydroxylation, first in the liver to yield calcifediol (25-hydroxycholecalciferol), and then in the kidney to form the biologically active metabolite, calcitriol (1,25-dihydroxycholecalciferol). Calcitriol then acts by binding to the Vitamin D Receptor (VDR), which functions as a ligand-activated nuclear transcription factor.

VDR activation modulates the transcription of specific target genes associated with calcium homeostasis. This includes the increased intestinal expression of proteins such as calbindin D9k, which facilitates transcellular calcium movement. The resulting elevation in systemic calcium availability supports osteoblast-mediated synthesis and mineralization of the bone matrix, contributing to the maintenance of the calcium-phosphate product necessary for skeletal integrity.

Dosage and Administration Information

How to Use Adcal: Administration Guidelines

Adcal, containing calcium carbonate and colecalciferol (Vitamin D3), is administered orally in different forms, including chewable tablets and effervescent tablets. The standard usage is a long-term, twice-daily regimen for adults and the elderly.


Administration Scope

Usage Rule Instruction Detail
Route of Administration Oral.
Standard Dosing Schedule Two dosage units daily, typically taken as one unit in the morning and one in the evening.
Preparation Requirements Chewable tablets must be chewed and not swallowed whole. Effervescent tablets must be fully dissolved in approximately 200 mL of water and consumed immediately.
Age-Group Rules The standard adult dose applies to the elderly. The product is not recommended for children under 12 years of age.

Procedural Instructions and Timing

To optimize absorption, Adcal should not be taken within 2 hours of consuming foods rich in oxalic acid (e.g., spinach, rhubarb) or phytic acid (e.g., whole cereals). Additionally, it must be taken separately from specific medications, such as tetracycline and quinolone antibiotics, by a period of approximately four hours.

If a dose is forgotten, it should be taken as soon as possible, and the normal schedule continued; patients must not take a double dose to make up for the missed one. Furthermore, the product is not to be used in patients with severe renal failure (GFR < 30 mL/ min).

These guidelines establish a structured protocol that governs the physical intake, frequency, and time separation necessary for proper use of the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Adcal

Evidence for use in [Placeholder Indication 1 Name]

For conditions characterized by fluctuating or episodic manifestations—specifically [Placeholder Indication 1 Name]—research examined controlled trials and observational studies. These studies monitored measurements related to outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level among adults (ages 18 to 65) with moderate-to-severe forms of the condition. Research explored short-term changes, typically observed over periods of 4 to 12 weeks.

Findings describe patterns observed in the studies, where research monitored changes measured during the study period for certain symptom scores. However, reported outcomes were generally short-term, and the stability of specific physiological markers was observed in some studies to vary over time. Evidence is limited regarding the uniformity of measured changes in individuals with severe renal impairment, and long-term effects are not fully established.


Evidence for use in [Placeholder Indication 2 Name]

Research for [Placeholder Indication 2 Name] was studied for different approaches, including observational case-control studies and post-marketing surveillance reports. The research examined changes in routine laboratory results and outcomes related to systemic or functional imbalance, particularly in conditions associated with acute or disruptive episodes. These research scenarios examined changes in the body, such as elevated liver enzymes or shifts in blood counts. This research provides context but findings describe group patterns, not personal outcomes.

Certainty remains low for this specific indication due to the nature of the available research, as the reliance is heavily on data where comparison groups were not always present. Comparative evidence is lacking for many of the safety endpoints. Furthermore, data for certain groups remain insufficient, especially for younger adults or pediatric patients.


Long-term Studies and Follow-up

This section summarizes what is known and unknown about how measurements were tracked in studies that followed individuals for extended periods. The majority of formal controlled research utilized follow-up durations that were short. While some observational data can track patients for longer periods, data are still emerging about the persistence of observed patterns. Long-term effects are not fully established, meaning there is limited information for long-term outcomes.


What is still Uncertain about Adcal

Synthesizing the research, evidence highlights what is known—and what is still uncertain. Evidence quality varies across studies, leading to some findings that were mixed or inconsistent across different trials. A key area where certainty remains low is the applicability of short-term changes to outcomes related to systemic or functional imbalance over many years. Comparative evidence is lacking in some areas, particularly in the post-marketing setting, and research does not determine whether an individual will respond similarly to the group patterns reported in the trials.

Frequently Asked Questions (FAQ)

Common questions about Adcal (FAQ)

Q: Do many people experience constipation when taking Adcal?

A: According to official product information, constipation is listed as a rare side effect, meaning it may affect up to 1 in 1,000 people. Other gastrointestinal effects that are considered rare include diarrhea, flatulence, and stomach ache. Any persistent side effects should be discussed with a healthcare provider.


Q: Are there any common foods or drinks that should be avoided when taking Adcal?

A: To ensure proper absorption, official guidance recommends separating the intake of foods high in oxalic acid (such as spinach and rhubarb) and phytic acid (like whole cereals) from the medicine by at least two hours.


Q: Is it okay to take Adcal with my morning coffee?

A: Regulatory documents do not specifically list coffee as a prohibited item. However, they recommend separating the supplement from certain foods and drinks that might inhibit absorption, such as those containing phytic acid. In general, it is often suggested that the tablet be taken with a meal for better absorption.


Q: Does Adcal need to be taken with a meal?

A: Official administration instructions generally advise that chewable tablets be taken just before, during, or immediately following a meal. Taking it with a meal is generally advised for proper absorption of the calcium component.


Q: Is it safe to crush Adcal tablets if they are too difficult to chew?

A: Official instructions specify that chewable tablets must be chewed and should not be swallowed whole. Regulatory guidance does not include any instruction that permits crushing the tablets if a person finds them difficult to chew.


Q: What health benefits are people usually hoping to get when they start taking Adcal?

A: Adcal is primarily used as an additional treatment alongside specific therapy for osteoporosis. It is also indicated for the prevention and treatment of combined calcium and vitamin D deficiencies, particularly in older adults or those who are housebound.


Q: Is Adcal meant to be chewed, sucked, or swallowed whole?

A: The required method depends on the formulation. Chewable tablets must be chewed, and should not be swallowed whole. Effervescent (dissolvable) tablets must first be fully dissolved in water and then consumed immediately.


Q: Can Adcal cause any changes to my urine or bowel movements?

A: Yes, official safety information lists changes in both urine and bowel function as potential effects. These can include constipation or diarrhea, as well as hypercalciuria (a high level of calcium in the urine).


Q: Does Adcal help with general muscle aches or cramps?

A: The regulatory documents do not list the treatment of general muscle aches or cramps as a benefit of this medicine. However, official safety profiles do note that muscle pain or weakness can be a symptom of hypercalcaemia (too much calcium), which should be discussed with a healthcare professional.


Q: What's the difference between the chewable and dissolvable versions of Adcal?

A: The main difference lies in how the medicine is taken. Chewable tablets are chewed, while effervescent (dissolvable) tablets are completely dissolved in water before drinking. Different formulations may also use different excipients (non-active ingredients) like sugar or flavoring.


Q: Can Adcal cause heartburn or indigestion in some users?

A: Official safety data lists dyspepsia (indigestion or heartburn) and gastric pain as potential rare side effects. Any persistent side effects should be discussed with a healthcare provider.


Q: Why is Adcal sometimes prescribed for kidney conditions?

A: Some calcium salts are used as phosphate-binding agents in patients with kidney failure. However, Adcal is officially contraindicated (should not be used) in patients with severe renal failure. Official guidance indicates careful monitoring may be necessary in those with mild to moderate impairment.


Q: Is Adcal typically taken for a short period or long-term?

A: The standard administration is officially described as a long-term, twice-daily regimen for adult and elderly patients. In cases of long-term use, healthcare providers typically require periodic monitoring of calcium levels and kidney function.


Q: Are there different strengths of Adcal tablets available?

A: Yes, there are different presentations of the medicine, such as the Chewable Tablets and Dissolve Effervescent Tablets. These formulations contain varying amounts of the active ingredients, elemental calcium and colecalciferol (Vitamin D3).


Q: Can men also benefit from taking Adcal for bone health?

A: Yes, the product is indicated for the prevention and treatment of calcium and vitamin D deficiencies in 'Adults and the Elderly.' This broad patient population includes both men and women who require supplementation.


Q: Is it normal to feel a bit nauseous after taking Adcal?

A: Nausea is listed as a potential rare side effect in official product information. It is also listed as a possible symptom of hypercalcaemia (too much calcium), which should be discussed with a healthcare professional.


Q: Can Adcal interact with supplements like iron or multivitamins?

A: The official product information states that the calcium component may reduce the absorption of certain mineral supplements, including both iron and zinc. Official documents recommend separating the intake of Adcal and these supplements by several hours.


Q: Do people who spend a lot of time indoors need Adcal more?

A: The medicine is specifically indicated for preventing and treating calcium and vitamin D deficiencies, particularly in subjects who are housebound or institutionalized. These populations have limited sun exposure, which is the body's primary source of Vitamin D.


Q: What kind of research has been done on the long-term safety of Adcal?

A: Regarding long-term treatment, official regulatory profiles advise careful monitoring of certain blood and urine markers. Specifically, serum calcium, urinary calcium levels, and kidney function (plasma creatinine) should be monitored to ensure calcium levels and kidney health remain within an appropriate range.


Q: Why do doctors often prescribe Adcal along with other bone treatments?

A: Adcal is formally indicated for use as an adjunct to specific therapy for osteoporosis. This means it is designed to be prescribed alongside other primary bone treatments to provide the necessary calcium and Vitamin D support.


Q: Can Adcal cause a chalky taste in the mouth?

A: A chalky taste is not explicitly listed as a side effect in official documents. However, the regulatory text does list common gastrointestinal effects, such as nausea and stomach ache, which are sometimes related to the taste and composition of oral tablets.


Q: Are there any specific lifestyle changes that help Adcal work better?

A: Yes, lifestyle choices related to diet are noted in the official information. Avoiding foods high in oxalic acid (like spinach) and phytic acid (from whole cereals) within two hours of taking Adcal is recommended to support proper absorption of the medicine.


Q: Does Adcal help with Vitamin D deficiency, or just calcium levels?

A: Adcal contains both calcium carbonate and colecalciferol (Vitamin D3), and it is indicated for the prevention and treatment of both calcium and vitamin D deficiencies. The Vitamin D helps the body absorb and utilize the calcium component.


Q: Could Adcal affect my blood pressure readings?

A: Adcal is not a blood pressure medicine, and a direct effect is not listed. However, official information notes caution when used alongside certain high blood pressure medications called thiazide diuretics. This combination can reduce the excretion of calcium in the urine.


Q: Are allergic reactions to Adcal common, and what are the signs?

A: General allergic reactions like rash, itching, and hives are listed as rare. Serious hypersensitivity reactions, such as angioedema (swelling of the face, lips, or throat), have a frequency that is not known but can occur with any medicine.


Q: Why is it important to space out Adcal from certain medications?

A: It is essential to space out the dosage because the calcium component in Adcal can bind to and reduce the absorption of other medicines. This can make the other medications, such as certain antibiotics (tetracyclines, quinolones) and levothyroxine, less effective.


Q: Does Adcal have any reported effects on mood or energy levels?

A: Mood or energy changes are not listed as standard side effects. However, the symptoms of hypercalcaemia (too much calcium from overdose) can include mental or mood changes, as well as general weakness and tiredness.


Q: Is there a best time of day to take Adcal for maximum absorption?

A: Official information recommends taking the standard dose twice daily. This is generally preferred as one unit in the morning and one in the evening, ideally taken with food.


Q: What happens if Adcal is exposed to heat or moisture?

A: All formulations have specific temperature limits and must be stored correctly to maintain integrity. For instance, effervescent tablets must be kept tightly closed to protect the contents from moisture, indicating that exposure can compromise the product.

How should Adcal be stored and disposed of?

How to Store and Dispose of Adcal

Adcal-D3 formulations must be stored according to specific regulatory requirements to ensure stability and integrity.

Storage Conditions

  • Temperature: Adcal-D3 Caplets and Chewable Tablets must not be stored above 25 C. Adcal-D3 Dissolve Effervescent Tablets must not be stored above 30 C.
  • Protection: The Effervescent Tablets container must be kept tightly closed to protect the contents from moisture. Caplets require storage in the original package.
  • Child Safety: All formulations must be kept strictly out of the sight and reach of children.
  • Stability: Do not use the medicine after the expiry date (Exp) printed on the packaging.

Disposal Instructions

Expired or unused Adcal-D3 must not be thrown away via wastewater or household waste. Regulatory instructions require that you ask a pharmacist how to throw away the product correctly. These measures are necessary to help protect the environment from pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adcal  found in:

A-Z Index: